Recombinant human monoclonal antibodies to human cytomegalovirus glycoprotein B neutralize virus in a complement-dependent manner.
about
The Immunology of Posttransplant CMV Infection: Potential Effect of CMV Immunoglobulins on Distinct Components of the Immune Response to CMVPhage display on the base of filamentous bacteriophages: application for recombinant antibodies selectionA high-affinity native human antibody neutralizes human cytomegalovirus infection of diverse cell typesHuman monoclonal antibodies as candidate therapeutics against emerging viruses and HIV-1.Complement enhances in vitro neutralizing potency of antibodies to human cytomegalovirus glycoprotein B (gB) and immune sera induced by gB/MF59 vaccination.
P2860
Recombinant human monoclonal antibodies to human cytomegalovirus glycoprotein B neutralize virus in a complement-dependent manner.
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Recombinant human monoclonal a ...... a complement-dependent manner.
@ast
Recombinant human monoclonal a ...... a complement-dependent manner.
@en
type
label
Recombinant human monoclonal a ...... a complement-dependent manner.
@ast
Recombinant human monoclonal a ...... a complement-dependent manner.
@en
prefLabel
Recombinant human monoclonal a ...... a complement-dependent manner.
@ast
Recombinant human monoclonal a ...... a complement-dependent manner.
@en
P2093
P1476
Recombinant human monoclonal a ...... a complement-dependent manner.
@en
P2093
Akane Ohta
Ayano Fujita
Tetsushi Yoshikawa
Tsugiya Murayama
Yoshikazu Kurosawa
Yoshitaka Iba
Yoshizo Asano
P304
P356
10.1016/J.MICINF.2009.07.010
P577
2009-08-03T00:00:00Z